What is Matinas BioPharma Holdings Inc?
, a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. The company is listed on the AMEX in USA, operating in the Healthcare sector, with a market capitalisation of 890.71K.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.